(Q1992653)

PubChem

PubChem CID

5311128

goserelin (English)

18 November 2016

CC(C)C[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)NNC(=O)N)NC(=O)[C@@H](COC(C)(C)C)NC(=O)[C@H](CC2=CC=C(C=C2)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC3=CNC4=CC=CC=C43)NC(=O)[C@H](CC5=CN=CN5)NC(=O)[C@@H]6CCC(=O)N6

1 reference

goserelin (English)

18 November 2016

0.129 milligram

1 reference

https://www.whocc.no/atc_ddd_index/?code=L02AE03

1 reference

14 February 2018

medical condition treated

endometriosis

1 reference

Drug Indications Extracted from FAERS

physically interacts with

2 October 2018

Gonadotropin releasing hormone receptor

subject has role

agonist

2 references

IUPHAR/BPS Guide to PHARMACOLOGY

Guide to Pharmacology Ligand ID

3879

English

17 August 2016

Open Targets Platform

14 August 2023

https://platform.opentargets.org/drug/CHEMBL1201247

LiverTox likelihood score

LiverTox toxicity likelihood category D

1 reference

8 April 2021

https://www.ncbi.nlm.nih.gov/books/n/livertox/Goserelin

last update

21 March 2018

subject has role

hormonal antineoplastic agent

1 reference

Medical Subject Headings

MeSH descriptor ID

D017273

15 March 2018

developmental toxicant

start time

26 August 1997

1 reference

California Proposition 65 list of chemicals

26 February 2020

https://oehha.ca.gov/chemicals/goserelin-acetate

male reproductive toxicant

start time

26 August 1997

1 reference

California Proposition 65 list of chemicals

26 February 2020

https://oehha.ca.gov/chemicals/goserelin-acetate

female reproductive toxicant

start time

26 August 1997

1 reference

California Proposition 65 list of chemicals

26 February 2020

https://oehha.ca.gov/chemicals/goserelin-acetate

Commons category

Goserelin

0 references

Identifiers

InChI

InChI=1S/C59H84N18O14/c1-31(2)22-40(49(82)68-39(12-8-20-64-57(60)61)56(89)77-21-9-13-46(77)55(88)75-76-58(62)90)69-54(87)45(29-91-59(3,4)5)74-50(83)41(23-32-14-16-35(79)17-15-32)70-53(86)44(28-78)73-51(84)42(24-33-26-65-37-11-7-6-10-36(33)37)71-52(85)43(25-34-27-63-30-66-34)72-48(81)38-18-19-47(80)67-38/h6-7,10-11,14-17,26-27,30-31,38-46,65,78-79H,8-9,12-13,18-25,28-29H2,1-5H3,(H,63,66)(H,67,80)(H,68,82)(H,69,87)(H,70,86)(H,71,85)(H,72,81)(H,73,84)(H,74,83)(H,75,88)(H4,60,61,64)(H3,62,76,90)/t38-,39-,40-,41-,42-,43-,44-,45+,46-/m0/s1

1 reference

based on heuristic

inferred from SMILES

2 references

goserelin (English)

18 November 2016

ChEBI release 2020-09-01

CAS Registry Number

65807-02-5

1 reference

Global Substance Registration System

UNII

0F65R8P09N

goserelin (English)

18 November 2016

1 reference

Goserelin (English)

18 November 2016

2 references

English

title

goserelin (English)

18 November 2016

imported from Wikimedia project

ChEBI ID

5523

mapping relation type

exact match

2 references

Spanish Wikipedia

International Chemical Identifier

1 reference

GOSERELIN (English)

18 November 2016

2 references

inferred from InChIKey

SCHEMBL8643

2 references

based on heuristic

inferred from InChIKey

Hazardous Substances Data Bank

1 reference

1 reference

28 October 2019

GOSERELIN (English)

10 May 2021

2 references

Mapping file of InChIStrings, InChIKeys and DTXSIDs for the EPA CompTox Dashboard

DSSTOX compound identifier

0 references

0 references

1 reference

ECHA Substance Infocard database

ECHA Substance Infocard ID

100.212.024

ECHA Substance Infocard ID

27 December 2018

title

N-[1-[[1-[[1-[[1-[[1-[[1-[[1-[2-[(carbamoylamino)carbamoyl]pyrrolidin-1-yl]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-[(2-methylpropan-2-yl)oxy]-1-oxopropan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-3-(3H-imidazol-4-yl)-1-oxopropan-2-yl]-5-oxopyrrolidine-2-carboxamide (English)

quotation

CAS no.: 65807-02-5 (English)

100.212.024

1 reference

ECHA Substance Infocard database

ECHA Substance Infocard ID

100.212.024